Skip Navigation

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (4)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Hiddemann, W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hiddemann, W.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Annals of Oncology 14:1163-1164, 2003
© 2003 European Society for Medical Oncology

Original Paper

ESMO Minimum Clinical Recommendations for diagnosis, treatment and follow-up of newly diagnosed follicular lymphoma

W. Hiddemann

Klinikum Grosshadern, Med. Klinik III, Hämatologie/Onkologie, München, Germany

The first 10% of the full text of this article appears below.


   Incidence
 
Follicular lymphomas present worldwide the second most frequent subtype of nodal lymphoid malignancies. The incidence of this disease has rapidly increased during recent decades and has risen from 5–6 cases/100 000/year during the 1950s to more than 13–15 cases/100 000/year recently.


   Diagnosis
 
Diagnosis should always be based on a surgical specimen/excisional lymph node biopsy providing enough material for fresh-frozen and formalin-fixed samples. To ensure . . . [Full Text of this Article]


   Staging and risk assessment
 

   Treatment plan
 

   Response evaluation
 

   Follow-up
 

   Note
 

   Literature
 

Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 BloodHome page
G. Lenz, M. Dreyling, E. Schiegnitz, R. Forstpointner, H. Wandt, M. Freund, G. Hess, L. Truemper, V. Diehl, M. Kropff, et al.
Myeloablative radiochemotherapy followed by autologous stem cell transplantation in first remission prolongs progression-free survival in follicular lymphoma: results of a prospective, randomized trial of the German Low-Grade Lymphoma Study Group
Blood, November 1, 2004; 104(9): 2667 - 2674.
[Abstract] [Full Text] [PDF]